Evidence map›Paper›PMID 26514360›Full record

ArticleJournal of neuro-oncology2016

Pituitary metastasis: is there still a place for neurosurgical treatment?

V Gilard, C Alexandru, F Proust, S Derrey, P Hannequin, O Langlois

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Pituitary metastasis from lung adenocarcinoma.World journal of clinical cases · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Pituitary metastasis of lung adenocarcinoma: Case report and literature review.International journal of surgery case reports · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

V GilardDepartment of Neurosurgery, Rouen University Hospital, 1, rue de Germont, 76031, Rouen Cedex, France. vianneygilard@hotmail.fr.ORCID http://orcid.org/0000-0001-6040-665X
C AlexandruDepartment of Oncology, Henri Becquerel Cancer Center, Rouen, France.
F ProustDepartment of Neurosurgery, Strasbourg University Hospital, Strasbourg, France.
S DerreyDepartment of Neurosurgery, Rouen University Hospital, 1, rue de Germont, 76031, Rouen Cedex, France.
P HannequinDepartment of Neurosurgery, Rouen University Hospital, 1, rue de Germont, 76031, Rouen Cedex, France.
O LangloisDepartment of Neurosurgery, Rouen University Hospital, 1, rue de Germont, 76031, Rouen Cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pituitary metastases are uncommon, ranging from 1 to 5 % of all metastases. Between 10 and 30 % of pituitary lesions are symptomatic responsible for diabetes insipidus, visual field defect or cranial nerve palsy. Primary sites are lung or breast in two-thirds of cases. There is no current reference concerning treatment of such lesions. Overall survival is poor and depends on primary site. Although the role of surgery is currently limited, discussion is warranted in several indications for diagnostic or symptomatic purposes. We report two cases of symptomatic pituitary metastases in a context of breast cancer and review the litterature concerning the role of surgery and other treatment modalities.

Indexed as

Breast NeoplasmsFemaleHumansMiddle AgedNeurosurgical ProceduresPituitary NeoplasmsTreatment OutcomePituitary gland- metastasesSurgical treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.